Technology for Good: GE Progresses on Cancer Research and Treatment
Technology for Good: GE’s Progress on Cancer Research and Treatment
“Nuclepore – another ’64 polymer advance – is now in production at Pleasanton, Calif., supplying medical and other customers with a filter whose extremely fine pores can be used in such ways as isolating cancer cells for medical research.”
For almost half a century GE has been on the front lines of cancer research. The company’s scientists and researchers have been central to the development and improvement of cancer screening tools that have detected cancer before it kills.
From the company’s earliest investment in x-ray machines, GE’s cancer screening tools are part of what is now a healthcare innovator that employs over 46,000 people worldwide and have saved countless more lives.
